Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Tanovea: The First FDA-Approved Dog Lymphoma Treatment | Dr. Douglas Thamm #162

Tanovea: The First FDA-Approved Dog Lymphoma Treatment | Dr. Douglas Thamm #162

FromDog Cancer Answers


Tanovea: The First FDA-Approved Dog Lymphoma Treatment | Dr. Douglas Thamm #162

FromDog Cancer Answers

ratings:
Length:
51 minutes
Released:
Apr 11, 2022
Format:
Podcast episode

Description

Lymphoma in dogs is very responsive to chemotherapy, but it also often relapses. Each time a dog comes out of remission, the cancer often gets harder to beat. Because of this, researchers are constantly looking for new treatments that can either get long-lasting results from the start or be used to beat back the cancer in those difficult cases.
Meet rabacfosadine, known by the brand name Tanovea. This drug is an injectable chemotherapeutic that just became the first ever FDA-approved treatment for lymphoma in dogs. Dr. Douglas Thamm, an oncologist at Colorado State University, has been working with Tanovea through most of its existence, and tells us all about how this drug came to be, how it works, and what we know so far about when it is most useful.
Links Mentioned in Today’s Show:
T-CHOP NAÏVE CANINE LYMPHOMA STUDY at Colorado State
Clinical Trials at University of Wisconsin
Clinical Trials at Oregon State University
Related Links:
Laverdia podcast episode
Lymphoma – What You Need to Know BEFORE You See the Oncologist
About Today’s Guest, Dr. Doug Thamm:
Dr. Thamm is the Barbara Cox Anthony Professor of Oncology and Director of Clinical Research at the Colorado State University Flint Animal Cancer Center. He is also a member of the Developmental Therapeutics Section of the University of Colorado Comprehensive Cancer Center and the Cell and Molecular Biology Graduate Program at Colorado State University. He has authored over 170 peer-reviewed publications and 20 book chapters in veterinary and basic cancer research, is Co-Editor for the most recent edition of the textbook Withrow and MacEwen’s Small Animal Clinical Oncology, and is Co-Editor-In-Chief of the journal Veterinary and Comparative Oncology. His clinical and research interests include novel targeted therapies for animal and human cancer and ways to integrate these therapies with existing treatment.
Other Links:
To join the private Facebook group for readers of Dr. Dressler’s book “The Dog Cancer Survival Guide,” go to https://www.facebook.com/groups/dogcancersupport/ 
Dog Cancer Answers is a Maui Media production in association with Dog Podcast Network
This episode is sponsored by the best-selling animal health book The Dog Cancer Survival Guide: Full Spectrum Treatments to Optimize Your Dog’s Life Quality and Longevity by Dr. Demian Dressler and Dr. Susan Ettinger. Available everywhere fine books are sold.
Have a guest you think would be great for our show? Contact our producers at DogCancerAnswers.com
Have an inspiring True Tail about your own dog’s cancer journey you think would help other dog lovers? Share your true tail with our producers.
If you would like to ask a dog cancer related question for one of our expert veterinarians to answer on a future Q&A episode, call our Listener Line at 808-868-3200 www.dogcanceransers.com.
Dog Cancer News is a free weekly newsletter that contains useful information designed to help your dog with cancer. To sign up, please visit: www.dogcancernews.com
Learn more about your ad choices. Visit megaphone.fm/adchoices
Released:
Apr 11, 2022
Format:
Podcast episode

Titles in the series (100)

If your dog has cancer, this podcast can help. Vetted advice from real veterinarians who answer your questions. Call our listener line to ask your question: 808-863-3200.